"Azithromycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.
Descriptor ID |
D017963
|
MeSH Number(s) |
D02.540.576.500.992.050
|
Concept/Terms |
Zithromax- Zithromax
- Azitrocin
- Azadose
- Ultreon
- Zitromax
|
Below are MeSH descriptors whose meaning is more general than "Azithromycin".
Below are MeSH descriptors whose meaning is more specific than "Azithromycin".
This graph shows the total number of publications written about "Azithromycin" by people in this website by year, and whether "Azithromycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 0 | 1 |
2011 | 1 | 0 | 1 |
2014 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Azithromycin" by people in Profiles.
-
Soku YK, Mohamed A, Samuel T, Dessai U, Walls I, Rockwell C, Fortenberry G, Berutti T, Nieves-Miranda S, Nawrocki EM, Fu Y, Dudley E, Mamber SW, Hicks J. A Comparative Study on Antimicrobial Resistance in Escherichia coli Isolated from Channel Catfish and Related Freshwater Fish Species. J Food Prot. 2024 01; 87(1):100192.
-
Diaby V, Almutairi RD, Chen Z, Moussa RK, Berthe A. A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19. Expert Rev Pharmacoecon Outcomes Res. 2021 Feb; 21(1):159-168.
-
Katz AR, Komeya AY, Kirkcaldy RD, Whelen AC, Soge OO, Papp JR, Kersh EN, Wasserman GM, O'Connor NP, O'Brien PS, Sato DT, Maningas EV, Kunimoto GY, Tomas JE. Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016. Clin Infect Dis. 2017 Sep 15; 65(6):918-923.
-
He X, Hwang HM, Aker WG, Wang P, Lin Y, Jiang X, He X. Synergistic combination of marine oligosaccharides and azithromycin against Pseudomonas aeruginosa. Microbiol Res. 2014 Sep-Oct; 169(9-10):759-67.
-
Katz AR, Komeya AY, Soge OO, Kiaha MI, Lee MV, Wasserman GM, Maningas EV, Whelen AC, Kirkcaldy RD, Shapiro SJ, Bolan GA, Holmes KK. Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States. Clin Infect Dis. 2012 Mar; 54(6):841-3.
-
Yamauchi Y, Kouyama T, Itakura S, Kamiya S, Nagase T, Sunazuka T, Omura S, Takizawa H. [The effects of macrolides (EM900, clarithromycin and azithromycin) on IL-17-induced IL-8 production by airway epithelial cells]. Jpn J Antibiot. 2009 Mar; 62 Suppl A:17-21.